Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer. | J Breast Cancer | 2026 | 41918184 | PubTator, text mining | PubMed |
| Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries. | JAMA Netw Open | 2026 | 41915393 | PubTator, text mining | PubMed |
| Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling. | Fam Cancer | 2026 | 41894033 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer. | Cancer Biol Ther | 2026 | 41879036 | PubTator, text mining | PubMed |
| Unraveling small non-coding RNAs with a significant post-transcriptional impact on breast cancer cell signaling, using a combinational sequencing approach. | Funct Integr Genomics | 2026 | 41866548 | PubTator, text mining | PubMed |
| Spatial tumor evolution panorama of ovarian cancer. | Cell Rep Med | 2026 | 41850247 | PubTator, text mining | PubMed |
| KAT2B-mediated epigenetic suppression of RAD51C enhances olaparib sensitivity in colorectal cancer. | Cancer Chemother Pharmacol | 2026 | 41826541 | PubTator, text mining | PubMed |
| Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High-Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale. | Hum Mutat | 2026 | 41809563 | PubTator, text mining | PubMed |
| NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer. | Cureus | 2026 | 41804394 | PubTator, text mining | PubMed |
| Germline BRCA testing in routine clinical practice: a single-center experience. | Pathol Oncol Res | 2026 | 41799566 | PubTator, text mining | PubMed |
| Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | 41799521 | PubTator, text mining | PubMed |
| Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance. | Oncol Res | 2026 | 41799499 | PubTator, text mining | PubMed |
| Pro-tumourigenic effects of DCAF13 on the progression of colorectal cancer. | Oncol Lett | 2026 | 41797888 | PubTator, text mining | PubMed |
| Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. | EBioMedicine | 2026 | 41797047 | PubTator, text mining | PubMed |
| Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic Variants. | Cancer Med | 2026 | 41795147 | PubTator, text mining | PubMed |
| Breast cancer inequities: the intersectional role of social epidemiology and tumor biology. | Cancer Causes Control | 2026 | 41784675 | PubTator, text mining | PubMed |
| Identification of Genetic Variants Among Breast Cancer Patients and At-Risk Individuals: A Cohort Study in Sri Lanka. | Breast Cancer (Auckl) | 2026 | 41783385 | PubTator, text mining | PubMed |
| Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique. | Surg Neurol Int | 2026 | 41783196 | PubTator, text mining | PubMed |
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2024". | Hered Cancer Clin Pract | 2026 | 41781972 | PubTator, text mining | PubMed |
| BCDX2-CX3 and DX2-CX3 complexes assemble and stabilize RAD51 filaments. | Nature | 2026 | 41772053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=3